SE444937B - N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat - Google Patents
N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivatInfo
- Publication number
- SE444937B SE444937B SE7910204A SE7910204A SE444937B SE 444937 B SE444937 B SE 444937B SE 7910204 A SE7910204 A SE 7910204A SE 7910204 A SE7910204 A SE 7910204A SE 444937 B SE444937 B SE 444937B
- Authority
- SE
- Sweden
- Prior art keywords
- imidazole
- ethyl
- alkyl
- group
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7848367 | 1978-12-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7910204L SE7910204L (sv) | 1980-06-14 |
SE444937B true SE444937B (sv) | 1986-05-20 |
Family
ID=10501705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7910204A SE444937B (sv) | 1978-12-13 | 1979-12-11 | N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat |
Country Status (34)
Country | Link |
---|---|
US (2) | US4602016A (fr) |
JP (1) | JPS585197B2 (fr) |
KR (1) | KR830001243B1 (fr) |
AR (1) | AR227637A1 (fr) |
AT (1) | AT373879B (fr) |
AU (1) | AU517892B2 (fr) |
BE (1) | BE880584A (fr) |
CA (1) | CA1108137A (fr) |
CH (1) | CH644597A5 (fr) |
CS (1) | CS216517B2 (fr) |
DD (1) | DD147943A5 (fr) |
DE (1) | DE2950019A1 (fr) |
DK (1) | DK471479A (fr) |
EG (1) | EG14227A (fr) |
ES (1) | ES486782A0 (fr) |
FI (1) | FI70888C (fr) |
FR (1) | FR2444031A1 (fr) |
GB (1) | GB2038821B (fr) |
GR (1) | GR73003B (fr) |
HU (1) | HU183016B (fr) |
IE (1) | IE49318B1 (fr) |
IL (1) | IL58917A (fr) |
IT (1) | IT1194900B (fr) |
LU (1) | LU81985A1 (fr) |
NL (1) | NL177749C (fr) |
NO (1) | NO153135C (fr) |
NZ (1) | NZ192360A (fr) |
PH (1) | PH15056A (fr) |
PL (1) | PL134005B1 (fr) |
PT (1) | PT70571A (fr) |
SE (1) | SE444937B (fr) |
SU (1) | SU878195A3 (fr) |
YU (1) | YU301879A (fr) |
ZA (1) | ZA796708B (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4350696A (en) | 1980-03-08 | 1982-09-21 | Pfizer Inc. | Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof |
US4444775A (en) * | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
DE3148291A1 (de) * | 1981-12-05 | 1983-06-09 | Basf Ag, 6700 Ludwigshafen | Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
JPS58113178A (ja) * | 1981-12-28 | 1983-07-05 | Yamanouchi Pharmaceut Co Ltd | 「お」−(1−イミダゾリル)アルキルオキシ(またはチオ)ベンゼン誘導体 |
US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
NL8301550A (nl) * | 1983-05-03 | 1984-12-03 | Gist Brocades Nv | Imidazolethanol esters. |
US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
IT1212791B (it) * | 1983-11-24 | 1989-11-30 | Medea Res Srl | Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono. |
ES8601148A1 (es) * | 1984-12-10 | 1985-11-16 | Ferrer Int | Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos. |
US4894385A (en) * | 1985-01-16 | 1990-01-16 | Sankyo Company Limited | Imidazole derivatives as inhibitors of TXA2 synthesis |
KR920002129B1 (ko) | 1986-01-27 | 1992-03-12 | 상꾜 가부시끼가이샤 | 티아나프텐 유도체의 제조방법 |
DE3786030T2 (de) | 1986-03-27 | 1993-12-02 | Merck Frosst Canada Inc | Tetrahydrocarbazole Ester. |
JPS63179840A (ja) * | 1986-07-24 | 1988-07-23 | Yamanouchi Pharmaceut Co Ltd | 新規化学物質 |
ATE57925T1 (de) * | 1987-04-03 | 1990-11-15 | Cl Pharma | Neue 2-thienyloxyessigsaeurederivate, ein verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. |
JPH01125372A (ja) * | 1988-09-12 | 1989-05-17 | Yamanouchi Pharmaceut Co Ltd | イミダゾリルアルキルオキシベンゼン誘導体 |
DE4204686A1 (de) * | 1992-02-17 | 1993-08-19 | Gruenenthal Gmbh | Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln |
AU2890899A (en) * | 1998-03-13 | 1999-09-27 | Pozen, Inc. | Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists |
ES2172436B1 (es) | 2000-10-31 | 2004-01-16 | Almirall Prodesfarma Sa | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
JP2005533830A (ja) * | 2002-07-09 | 2005-11-10 | ビー.エム.アール.エイ. コーポレイション ベスローテン フェンノートシャップ | トロンボキサンa2受容体アンタゴニストおよびcox−2阻害剤の薬剤の組み合わせ |
JP2007508242A (ja) * | 2003-08-07 | 2007-04-05 | ビー.エム.アール.エイ. コーポレイション ベスローテン フェンノートシャップ | トロンボキサンa2受容体アンタゴニストとシクロオキシゲネーゼ−1の阻害剤との組み合わせを伴う組成物および方法 |
KR101275814B1 (ko) * | 2006-06-23 | 2013-06-18 | 삼성에스디아이 주식회사 | 분산제 화합물 및 그의 제조방법 |
EP2234608A2 (fr) | 2007-12-11 | 2010-10-06 | Viamet Pharmaceuticals, Inc. | Inhibiteurs de métalloenzymes utilisant des fractions de liaison à un métal en combinaison avec des fractions de ciblage |
CN101811974B (zh) * | 2010-04-15 | 2012-12-12 | 合肥医工医药有限公司 | 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途 |
CN101851209B (zh) * | 2010-06-21 | 2012-09-19 | 合肥医工医药有限公司 | 咪唑乙基香草酸醚、其制备方法及其医药用途 |
EA026393B1 (ru) * | 2012-05-22 | 2017-04-28 | Дженентек, Инк. | N-замещенные бензамиды и их применение в лечении боли |
BR112015008987A2 (pt) | 2012-10-26 | 2017-07-04 | Merck Sharp & Dohme | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de uma composição farmacêutica |
WO2023240378A1 (fr) * | 2022-06-13 | 2023-12-21 | 南京医工医药技术有限公司 | Dérivé d'éther d'acide imidazolidinyl-vanillique et son utilisation |
CN114736161B (zh) * | 2022-06-13 | 2022-09-13 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3534061A (en) * | 1967-12-04 | 1970-10-13 | Parke Davis & Co | N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles |
US4085209A (en) * | 1975-02-05 | 1978-04-18 | Rohm And Haas Company | Preparation and safening effect of 1-substituted imidazole metal salt complexes |
US4078071A (en) * | 1976-03-08 | 1978-03-07 | Syntex (U.S.A.) Inc. | Derivatives of substituted N-alkyl imidazoles |
JPS5951943B2 (ja) * | 1978-08-21 | 1984-12-17 | キツセイ薬品工業株式会社 | 新規なイミダゾ−ル誘導体 |
-
1979
- 1979-11-07 DK DK471479A patent/DK471479A/da not_active Application Discontinuation
- 1979-11-19 US US06/095,755 patent/US4602016A/en not_active Expired - Lifetime
- 1979-12-10 AR AR279215A patent/AR227637A1/es active
- 1979-12-10 GB GB7942535A patent/GB2038821B/en not_active Expired
- 1979-12-11 SE SE7910204A patent/SE444937B/sv unknown
- 1979-12-11 HU HU79PI699A patent/HU183016B/hu unknown
- 1979-12-11 GR GR60727A patent/GR73003B/el unknown
- 1979-12-11 PT PT70571A patent/PT70571A/pt unknown
- 1979-12-11 ES ES486782A patent/ES486782A0/es active Granted
- 1979-12-11 NL NLAANVRAGE7908899,A patent/NL177749C/xx not_active IP Right Cessation
- 1979-12-11 NZ NZ192360A patent/NZ192360A/xx unknown
- 1979-12-11 YU YU03018/79A patent/YU301879A/xx unknown
- 1979-12-11 FI FI793868A patent/FI70888C/fi not_active IP Right Cessation
- 1979-12-11 IT IT41669/79A patent/IT1194900B/it active
- 1979-12-11 ZA ZA00796708A patent/ZA796708B/xx unknown
- 1979-12-11 IL IL58917A patent/IL58917A/xx unknown
- 1979-12-12 PL PL1979220351A patent/PL134005B1/pl unknown
- 1979-12-12 KR KR1019790004397A patent/KR830001243B1/ko active
- 1979-12-12 DE DE19792950019 patent/DE2950019A1/de not_active Ceased
- 1979-12-12 NO NO794069A patent/NO153135C/no unknown
- 1979-12-12 AT AT0783379A patent/AT373879B/de not_active IP Right Cessation
- 1979-12-12 AU AU53725/79A patent/AU517892B2/en not_active Ceased
- 1979-12-12 BE BE0/198542A patent/BE880584A/fr not_active IP Right Cessation
- 1979-12-12 SU SU792854456A patent/SU878195A3/ru active
- 1979-12-12 IE IE2403/79A patent/IE49318B1/en unknown
- 1979-12-12 EG EG743/79A patent/EG14227A/xx active
- 1979-12-12 LU LU81985A patent/LU81985A1/fr unknown
- 1979-12-12 CS CS798708A patent/CS216517B2/cs unknown
- 1979-12-12 FR FR7930438A patent/FR2444031A1/fr active Granted
- 1979-12-12 JP JP54161382A patent/JPS585197B2/ja not_active Expired
- 1979-12-12 CA CA341,691A patent/CA1108137A/fr not_active Expired
- 1979-12-13 DD DD79217645A patent/DD147943A5/de unknown
- 1979-12-13 CH CH1106279A patent/CH644597A5/de not_active IP Right Cessation
- 1979-12-13 PH PH23412A patent/PH15056A/en unknown
-
1985
- 1985-03-21 US US06/714,422 patent/US4636500A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE444937B (sv) | N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat | |
US4273782A (en) | Inhibition of thromboxane synthetase by 3-(1-Imidazolylalkyl) indoles | |
US4448781A (en) | N-Benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme | |
EP0035863B1 (fr) | Dérivés d'imidazole, procédé pour leur préparation et leurs compositions pharmaceutiques | |
US4339583A (en) | (Imidazolylmethyl)pyridine compounds as thromboxane synthetase inhibitors | |
EP0054417B1 (fr) | Indoles inhibiteurs de la thromboxane synthétase, procédé de préparation et compositions pharmaceutiques les contenant | |
GB2041363A (en) | N-Benzyl-imidazoles | |
US4451472A (en) | Inhibition of thromboxane synthetase with 3-(heteroalkyl)-indolyl-acrylic acid derivatives | |
GB2065121A (en) | Isoquinoline Derivatives | |
US4347371A (en) | Disulfide compounds | |
GB2045244A (en) | 3-1-(Imidazolylalkyl) indoles | |
PL103682B1 (pl) | Sposob wytwarzania nowych pochodnych indazoliloksy-4-propanoloaminy | |
GB2068950A (en) | Pyridine Derivatives | |
GB2101115A (en) | Thromboxane synthetase inhibitors | |
GB2102795A (en) | Indole derivatives | |
RU2322440C1 (ru) | Замещенные омега-азолилалкананилиды, способ их получения и применение в качестве антиагрегантов | |
JPS6323848A (ja) | Ω−(置換フエニルオキシ)−アルカン酸のアリ−ル−およびアラルキルアミド |